Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.94%), DAX (0.81%), CAC40 (0.57%)

Nov 06 ,2026

  • Synopsis

    • European indices will most likely open lower as Asian stock markets steadying in midday trade Friday with sharp declines across region and sectors but many indexes off their lows. MSCI Asia Pac ex Japan index down around 3.9% from 5.8% earlier.

    • US equities were notably lower in Thursday trading as stocks ended near worst levels. Major indices more than erased Wednesday's big post-election gains; S&P, Nasdaq, and Russell 2000 all saw their worst sessions since Apr-25.

    • AI trade under pressure after opening Kospi plunge triggered circuit breaker. Samsung and SK Hynix hit lowest since early 2026.

    • President Trump said time has come to make decision on Iran. Press sources noted strikes one option under consideration, along with reaching an agreement. Some talk about potential breakthrough on nuclear with two sides reviewing proposals.

    • Friday sees, in central banks, Denmark central bank's Nødgaard speech at 10:00CET at the general meeting of the National Bank of Denmark. ECB's Donnery speech at 10:01CET at 13th Annual IIF Colloquium on European Banking Regulation & Supervision. Hungary and Austria central bank's jointly host The pros and cons of euro adoption in CESEE at 10:00CET at workshop. ECB's Lane fireside chat at 10:30CET at ECB Money Market Conf. BOE's Pill and Shortall at National MPC Agency briefing at 12:15GMT. Czech central bank Monetary Policy Report pre-release. Bank of Italy's latest economic survey of industrial and service firms. Russia Oct new car registrations

    • Economic data due today: Germany Sep industrial production, France Sep trade balance, Spain Sep industrial production, Eurozone Sep retail sales, UK Oct house price index - Lloyds, Switzerland Oct consumer confidence, Norway Sep manufacturing production, Denmark Sep industrial production,

    • Earnings reported this morning: Aperam (APAM.NA), bnode (BPOST.BB), Daimler Truck Holding (DTG.GR), Krones (KRN.GR), Data Modul (DAM.GR), Schouw & Co (SCHO.DC), Outokumpu (OUT1V.FH), Tokmanni Group (TOKMAN.FH), Teleste (TLT1V.FH)

    • Orkla (ORK.NO), AKVA Group (AKVA.NO), Sea1 Offshore (SEA1.NO), Hexagon Composites (HEX.NO), Hofseth BioCare (HBC.NO)

    • Cellnex Telecom (CLNX.SM), Logista Integral (LOG.SM), Piaggio & C (PIA.IM), Attendo (ATT.SS), Haypp Group (HAYPP.SS), BTS Group (BTS.B.SS), Egetis Therapeutics (EGTX.SS), Viking Supply Ships (VSSAB.B.SS), Cavotec (CCC.SS), Arla Plast (ARPL.SS),

  • Politics/Macro/World News

    • ECB's Lagarde says data will tell if December rate hike needed (Reuters )

    • Belgian Government Crisis Risks Delaying Nuclear, Banking Deals (Bloomberg )

  • Top company news

    • Earnings/updates

      • DTG.GR (Daimler Truck Holding) -- reports Q3 EPS €0.91 vs FactSet €1.03 [3 est, €0.95-1.07]; FY26 guidance confirmed

      • CLNX.SM (Cellnex Telecom) -- reports 9M adj. EBITDA €2.55B vs consensus €2.44B; reiterates 2026 guidance and 2027 outlook

      • TEP.FP (Teleperformance) -- reports Q3 revenue €2.53B vs FactSet €2.56B [1 est]

      • ENX.FP (Euronext) -- reports Q3 EPS €2.17 ex-items vs consensus €2.08

      • GNFT.FP (GENFIT) -- reports 9M revenue €36.4M, (7%) vs year-ago €39.2M

      • PIRC.IM (Pirelli & C.) -- reports Q3 net income €131.2M vs consensus €126M; reaffirms targets notwithstanding the worsening of the external context

      • NYXH.BB (Nyxoah) -- reports Q3 EPS (€0.18) vs FactSet (€0.31) [5 est, (€0.54)-(0.21)]

      • APAM.NA (Aperam) -- reports Q3 adjusted EBITDA €105M vs FactSet €107.7M [5 est, €100-118M]

      • A531.GR (Aura Minerals) -- reports Q3 adjusted net income $121.2M, +76% vs year-ago $68.7M

      • GBLB.BB (Groupe Bruxelles Lambert) -- reports Q3 NAVPS €99.21, (5%) vs year-ago €104.83

      • BAMI.IM (Banco BPM) -- reports Q3 net income €452.5M vs FactSet €431.6M [7 est, €415-446M]; reaffirms FY net income guidance, raises dividend guidance

      • GUBRA.DC (Gubra A/S) -- reports Q3 EBIT DKK317.7M vs FactSet DKK344.0M [1 est]

      • ORK.NO (Orkla) -- reports Q3 EPS NOK1.94 vs FactSet NOK1.68 [7 est, NOK1.58-1.92], remains on track to meet targets for EBIT (adj.) growth and margin expansion

      • MB.IM (Mediobanca) -- reports Q3 net income €378.9M, +30% vs year-ago €291.0M; reaffirms FY guidance

      • CO.FP (Casino Guichard-Perrachon) -- Postpones Q3 2026 activity release

      • MOVE.SW (Medacta Group) -- SA updates guidance for 2026 and reiterates 2024-2027 mid-term outlook

      • KRN.GR (Krones) -- reports Q3 EPS €2.55 vs FactSet €2.40 [3 est, €2.32-2.51]

      • AMG.NA (AMG Critical Materials) -- reports Q3 EPS $0.61 vs FactSet $0.85 [1 est]

      • VCT.FP (Vicat) -- reports Q3 revenue €1.09B vs FactSet €1.06B [2 est, €1.06-1.06B]

      • STM.GR (Stabilus) -- reports preliminary Q4 adjusted EBIT €28.9M vs year-ago €34.0M

      • ATT.SS (Attendo) -- reports Q3 adj. EPS SEK2.93 vs FactSet SEK2.65 [4 est, SEK2.53-2.71]

      • MOL.HB (MOL Hungarian Oil & Gas) -- reports Q3 net income attributable Ft252.35B vs FactSet Ft274.26B [3 est, Ft253-289.78B]

      • JST.GR (JOST Werke) -- raises outlook for FY26

      • CLAS.B.SS (Clas Ohlson) -- reports Oct sales SEK1.25B; +12% y/y organic growth

      • GDS.FP (Ramsay Générale de Santé) -- reports Q1 net income (€35.5M) vs year-ago (€40.1M)

      • GGP.LN (Greatland Resources) -- reaffirms FY27 growth capex A$315-335M at Telfer and A$365-435M at Havieron in presentation

      • CE.IM (Credito Emiliano) -- reports 9M net income €458.8M ex-items, +13% vs year-ago €407.7M

    • M&A

      • ECMPA.NA (Eurocommercial Properties) -- completes acquisition of Les Grands Prés, in Belgium

      • ADKO.AV (Addiko Bank) -- Raiffeisen Bank International tender offer for Addiko Bank AG totals 96.8% of offer shares

    • Healthcare

      • IPN.FP (Ipsen) -- announces late-breaking data from the ELSPIRE Phase III study in people living with primary biliary cholangitis and alkaline phosphatase levels between 1- 1.67× upper limit of normal

      • MOLN.SW (Molecular Partners) -- Presents New Preclinical Data for Next-Generation T Cell Engager MP0632 at SITC 2026

      • PHARM.NA (Pharming Group) -- MHRA approves Pharming's Joenja (leniolisib) as first treatment specifically for children with APDS in the U.K.

      • BINV.SS (BioInvent International) -- reports final terms for the Rights Issue of approximately SEK 430M

    • Other

      • KER.FP (Kering) -- announces departure of Pierpaolo Piccioli as Creative Director of Balenciaga

      • IAG.LN (International Consolidated Airlines Group) -- approves 2026 interim dividend of €0.053/share (gross)

      • SCHP.SW (Schindler Holding) -- completes share buyback program

      • AF.FP (Air France-KLM) -- Group, KLM welcome ruling by Court of Justice of EU, which sets aside judgment of General Court of EU of 7-Feb-24

      • CCH.LN (Coca-Cola HBC) -- responds to press speculation; received no notification from Russian government of any changes to operations

      • VK.FP (Vallourec) -- announecs €750M credit facility

      • EMG.LN (Man Group) -- notes judgment of High Court delivered today in relation to claim brought by PIFSS

      • FNTN.GR (Freenet) -- to launch €75M share buyback program

      • ARYN.SW (Aryzta) -- CFO Martin Huber leaving to pursue outside executive opportunity

      • EXENS.FP (Exosens) -- climate objectives validated by SBTi

      • EXENS.FP (Exosens) -- Follow-up: Exosens climate targets validated by SBTi

  • Key rating changes

    • Upgrades

      • SOLB.BB (Solvay) -- to hold from sell at Berenberg

    • Downgrades

      • PUB.FP (Publicis Groupe) -- Publicis Groupe assumed neutral at UBS

      • SOON.SW (Sonova Holding) -- to sector perform from outperform at RBC Capital Markets

      • KNIN.SW (Kuehne & Nagel) -- to neutral from buy at Goldman Sachs

      • TRN.LN (Trainline) -- to hold from buy at Peel Hunt

      • YUBICO.SS (Yubico) -- to hold from buy at DNB Carnegie

    • Initiations

      • ISS.DC (ISS A/S) -- outperform at RBC Capital Markets

  • Data

    • Nikkei (6.17%) to 57308.15

    • Hang Seng (0.98%) to 24553.18

    • Shanghai Composite (1.02%) to 3652.26

    • S&P futures (3.3) vs prior close of 7383.0

    • €-$ (0.0025) or (0.22%) to 1.1194

    • $-¥ +0.18 or +0.11% to 157.86

    • €-¥ (0.22) or (0.12%) to 176.69

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.